key: cord-0252666-nh6ujlr7
authors: Sharif, Asmaa Fady; Mattout, Sara Kamal; Mitwally, Noha Adel
title: Coronavirus disease-19 spread in the Eastern Mediterranean Region, updates and prediction of disease progression in Kingdom of Saudi Arabia, Iran, and Pakistan
date: 2020
journal: Int J Health Sci (Qassim)
DOI: nan
sha: 92d0d78901b353ef7d3c975f84bc3dc2f675c982
doc_id: 252666
cord_uid: nh6ujlr7

OBJECTIVES: The present study is considered the first study that aims to estimate the spread of coronavirus disease (COVID)-19 pandemic in the Eastern Mediterranean Region and to predict the pattern of spread among Kingdom of Saudi Arabia (KSA) in comparison to Iran and Pakistan. METHODS: Data during the period from January 29, 2020, till April 14, 2020, were extracted from 76 WHO situational reports and from the Worldometer website. Numbers of populations in each country were considered during data analysis. Susceptible, infectious, recovered, and deaths (SIRD) model and smoothing spline regression model were used to predict the number of cases in each country. RESULTS: SIRD model in KSA yielded β = 2e-0.6, γ = 0.006, and μ = 0.00038 and R(0)= 0.00029. It is expected that by the 1(st) of May 2020, that number of cumulative infected cases would rise to 16848 in KSA and to 11,825 in Pakistan while in Iran, it is expected that the number mostly will be 100485. Moreover, the basic reproduction number R(0) is expected to decrease by time progression. CONCLUSION: The cumulative infected cases are expected to grow exponentially. Although R(0) is expected to be decreased, the quarantine measures should be maintained or even enhanced.

Vol. 14, Issue 5 (September -October 2020) et al. concluded that the existing epidemic has been driven entirely by a human to human transmission through droplets or direct contact. [3] Within a few weeks, the virus spread rapidly throughout China and within 1 month disseminated to several other countries, including the Eastern Mediterranean Region. [6] Under the electron microscope, the new strain SARS-CoV-2 is an enveloped single-stranded positive-sense RNA virus-like all known coronaviruses. Its genome consists of around 29,900 nucleotides. SARS-CoV-2 is considered as a SARS related coronavirus. [7] This is evidenced by the phylogenetic analysis done by Zhu et al. According to their analysis, SARS-CoV-2 belongs to the harmful genus β coronavirus, which includes SARS-CoV and MERS-CoV and infects humans, bats, and wild animals. [8, 9] Upon comparing the nucleotide sequences, SARS-CoV-2 is 80% identical to SARS-CoV and 50% to MERS-CoV. [10, 11] SARS-CoV-2 genome organization contains four main structural genes, which encode for spike protein (S), envelope (E), nucleocapsid protein (N), and membrane (M); in addition to other accessory membrane glycoproteins on the S called receptor binding domains (RBD), these proteins interfere with the host innate immunity and defense mechanism. [12] In all coronaviruses, the RBD is the most variable part of the genome structure. [13, 14] Through the RBD of the S protein, SARS-CoV-2, similarly to SARS-CoV, targets Angiotensin-Converting Enzyme 2 (ACE2) of the human body as a receptor. This clarifies the pathogenesis of SARS-CoV and links its genetic composition to its harmful effect; moreover, it opens the way to the therapeutic solution of the infection. [14] On January 30, 2020, the WHO stated the COVID-19 outbreak as the sixth public health emergency of international concern, following H1N1 (2009), polio (2014), Ebola in West Africa (2014), Zika (2016), and Ebola as well in the Democratic Republic of Congo (2019). Consequently, health workers, governments, and the public need to cooperate globally to prevent its dissemination. [15] Upon penetration of the SARS-COV-2 virus to the larynx and nasal mucous membrane, it may reach the human lower respiratory tract, then it would cause viremia by escaping from the lung to the blood. [16] The spike glycoprotein (S) of the virus binds initially to the cellular receptor angiotensinconverting enzyme 2 (ACE2). Consequently, ACE2 is considered as a target of SARS-CoV. [12] The virus attaches all tissues expressing ACE2 such as the lungs, heart, renal, and gastrointestinal tract. [17, 18] This is called the Viremia phase; then, a significant gradual decrease in the lymphocytes in patients with COVID-19 is noticed as the disease progresses, but the mechanism is unknown. Moreover, the inflammatory markers and the cytokines such as IL-6 are increased, contributing to the worsening of the disease, which will take the patient to the pneumonia phase. [16, 19] According to Lin et al. the pneumonia phase of the disease is very critical if the patient is elderly or his immune system is impaired or with the presence of comorbidities such as chronic diseases such as hypertension and diabetes, the patient will not be able to enter the (Recovery phase) and will become critically ill. Since there is no specific treatment of COVID-19 until now, the treatment should target the control of lymphocytes and the inflammatory markers. [16] Although the unclear specific presentation of COVID-19 infected cases and similar to all other human coronaviruses (229E, OC43, HKU, and NL63), the majority of cases reported a history of multiple previous days illness or flu-like symptoms resembling seasonal influenza, mild to moderate myalgia, dizziness, fatigue, nonproductive cough, and fever. Some uncommon cases reported gastrointestinal symptoms. [4] Regarding the pediatrics, their involvement is less than the adults and those infected with COVID-19 were reported to be mild with favorable outcomes. [20] Many studies proved that the old aged cases with comorbidities such as diabetes and previous pulmonary illness are riskier as they are commonly presented with severe dyspnea and shock and their conditions mostly deteriorate to respiratory failure. [21] Clinical physical examination of the mild cases is usually unremarkable, but the severely affected cases are presented with pulmonary hemodynamic instability, high fever with increased respiratory rate, and heart rate associated with low oxygen saturation, which are commonly encountered. In pediatrics, hemorrhagic skin patches and oliguria may be additively seen. During chest auscultation, wheezes and crepitation may be audible. [4] The course of the infection cannot be determined, some cases end up mild pneumonia while the others deteriorate into acute respiratory distress syndrome (ARDS) that necessitates advanced life support. [20] Added to the ARDS, many other complications are observed such as septic shock, cardiac and renal injuries, and multi-system organ failure. [22] Many diagnostic procedures might help in diagnosis and monitoring of the cases like O 2 saturation assessment by pulse oximetry and chest plain imaging and computed tomography (CT) scans that aid in lung visualization. Although normal CT does not rule out, the diagnosis but still considered as an excellent sensitive tool. [23] Polymerase chain reaction (PCR) is another mean that confirms the positive COVID-19 cases, analysis of serum samples revealed positive SARS-CoV-2 (2019-nCoV). RNA by PCR is considered confirmatory. CDC recommends the collection of samples from the upper and lower respiratory tract under certain precautions. [24] Other nonspecific lab finding reported among those infected with COVID-19 such as leucopenia, anemia, prolonged prothrombin time, and elevated serum lactate. [25] Up till now, there is no effective antiviral therapy or vaccine against COVID-19 and the only option is focused on symptomatic treatment and respiratory support. [12] It is proved that a combination between the two antiretroviral drugs

Vol. 14, Issue 5 (September -October 2020) lopinavir and ritonavir significantly improved the clinical condition of SARS-CoV-patients which may be useful for SARS-COV-2 patients as well. [26] Promisingly, an in vitro study, proved the effectiveness of remdesivir and chloroquine combination for inhibiting the novel SARS-CoV-2. [12] There is a desperate need for new medicines to treat COVID-19, a vaccine to prevent infection entirely would be even better.

Many studies were conducted and implemented many different types of predictive models to assess the current situation and predict the future rates of fatalities and deaths in different countries. Among these countries, few works of literature mentioned the situation in Iran and Pakistan; [27, 28] however, there is no literature about the current situation of COVID-19 disease caused by the novel SARS-CoV-2 in Kingdom of Saudi Arabia (KSA). The present study is considered the first study that aims to estimate the spread of COVID-19 pandemic among KSA in comparison to Iran and Pakistan. Added to that, the study utilized the susceptible, infectious, recovered, and deaths (SIRD) model and smoothing spline regression model to predict the number of cases in each country during the coming weeks.

The current study involved all countries (20 countries) within the Eastern Mediterranean Region (Iran, Pakistan, Saudi Arabia, United Arab Emirates, Qatar, Egypt, Morocco, Iraq, Kuwait, Bahrain, Tunisia, Lebanon, Oman, Afghanistan, Jordan, Djibouti, Libya, Syria, Sudan, and Somalia). Later on, Syria, Libya, Sudan, Djibouti, and Somalia were excluded from the analysis as the appearance of the disease among those countries did not complete 4 weeks yet. The study went in detail among the three countries Iran, KSA, and Pakistan. We chose Iran and Pakistan to be compared with Saudi Arabia as both proceeded KSA in recording COVID-19 positive cases, Iran was among the first countries reported the disease appearance. Added to that, Iran and Pakistan had a relatively high number of populations among the region. Lastly and although few, there were previous studies in both Iran and Pakistan regarding COVID-19 spread.

Data were extracted from the WHO situational reports [6] that include all the studied variables other than the recovery data, so we got the recovery data from Worldometer [29] which was announced by the American Library Association as one of the best data sources, and it is approved and trusted by many governments. The study included 76 situational reports, starting from the situational report number 9 dated January 29, 2020, to the situational report number 85 dated April 14, 2020. The number of populations in each country was considered during data analysis.

The following daily parameters for each country were included; the number of the cumulative confirmed cases, newly confirmed cases, cumulative recovered cases, newly recovered cases, total cumulative deaths, and new deaths. Considered time is measured in days. The numbers were recorded in a spread-sheet and checked twice by different observers to avoid errors.

The data were analyzed by R software statistical programming language, version 3.6.1 (July 5, 2019) (R Foundation for Statistical Computing). For all included countries, descriptive statistics describing the prevalence of the disease in the first 4 weeks after recording the first positive case were conducted, the proportion of infected cases was described as medians and interquartile range and compared with Kruskal-Wallis rank-sum test and Dunn (1964) Kruskal-Wallis multiple comparison test after the normality (tested with Shapiro-Wilk normality test which showed that the data are not normally distributed. P < 0.05 are considered significant with 95% confidence level). The skewness of the data obtained from the different countries is logical as the disease is increasingly spreading. After that, and among the three countries, Iran, KSA, and Pakistan, the proportions of recovered and died cases were also included in the study.

As COVID19 is one of the spreading diseases in which the disease progression can be well assessed by applying the predictive models, among the three countries, Iran, Saudi Arabia, and Pakistan, we implemented the SIRD model to predict the progression of the disease in the next coming weeks. SIRD model simply represents the disease progression within a discrete area. [30] In the SIRD model and due to the short duration of the study and due unavailability of numbers of susceptible individuals, we assumed the whole population as being susceptible, this encouraged us to search for another regression predicting model that can accurately predict the numbers of infected cases in the next coming weeks. Smoothing spline regression model was conducted, and the cumulative infected cases versus time were plotted. Furthermore, the performance of the model is tested and the cumulative number of cases in the next weeks is predicted. Table 1 showed the prevalence of the disease among the studied period. Table 2 showed the median values of cumulative infected cases in each country in the 4 weeks following the appearance of the first positive case. There were significant differences (P < 2.2e-16) between the 15 countries regarding the proportions of cumulative infected cases to the overall population. Multiple comparison tests showed that there was a significant difference (P-value [adjusted] <0.05) between many countries and each other.

Vol. 14, Issue 5 (September -October 2020)

The comparison was conducted in the first 4 weeks from the first infected case discovered, Qatar was significantly higher in infection rate than Afghanistan, Egypt, Iraq, Jordan, KSA, UAE, Morocco, and Pakistan. Added to that, Al Bahrain was significantly higher in infection rate than UAE, Pakistan, Oman, Lebanon, Afghanistan, Egypt, Jordan, Tunisia, Iraq, KSA, and Morocco. Finally, Iran was significantly higher in infection rate than Afghanistan, Egypt, Morocco, Pakistan, UAE, and Tunisia in the first 4 weeks from the first infected case discovered

On the other side, Pakistan was significantly lower in infection rates than Iran, Al Bahrain, KSA, Qatar, Kuwait, Oman, and Lebanon. Egypt was significantly lower in infection rates than Al Bahrain, Qatar, KSA, Morocco, Oman, UAE, Jordan, Iran, Iraq, Kuwait, and Lebanon in the first 4 weeks from the first infected case discovered.

Regarding the scope of the current study, and among the three mentioned countries, the population number in Iran is 37,203,000 compared to 32,276,000 in Saudi Arabia. Pakistan shows the highest number of populations (193,203,000). The prevalence per 100,000 population among the three countries showed that Iran exhibited the highest prevalence (net prevalence) of infected cases 66 (38) followed by KSA 6 (4) and finally Pakistan 2 (1).

Those differences were further assessed for their significance by comparing the median values of cumulative infected, recovered, and death cases among the different countries in the first 4 weeks following the first positive case diagnosis. There was a statistically significant difference (P = 3.932e-07) between KSA, Iran, and Pakistan by Kruskal-Wallis rank-sum Tables 5 and 6 .

Regarding the cumulative deaths in the concerned countries, Tables 7 and 8, there was a statistically significant difference (p-value = 3.966e-13) between KSA, Iran, and Pakistan by Kruskal-Wallis rank-sum test and by comparisons between every two groups by Dunn (1964) Kruskal-Wallis multiple comparison tests, it was shown that there was a significant difference (p-value (adjusted) < 0.05) between Iran and KSA and between Iran and Pakistan. Iran has a significantly higher cumulative death compared to KSA and Pakistan with median (1.052605e-06, 0, 0), respectively, in the first 4 weeks in each country. Figure 2a -c and Figure 3 illustrated that during the first 4 weeks after reporting the first case of COVID-19 in the three studied countries (Iran, Saudi Arabia, and Pakistan), Iran showed the highest number of cumulative infected, recovered, and death cases.

A curve showing that Iran has the highest number of cumulative infected, recovered, and death cases on a confidence level 95% compared to KSA and Pakistan during the first 4 weeks of infection.

The current study considered the Susceptible-Infectious-Recovered-Dead (SIRD) model, a compartmentalized type model, which is a simple representation of disease progression with discrete states. When approaching modeling mathematically, we utilized a set of equations to describe bulk population dynamics. 

Conducting the SIRD compartmentalized model in Iran revealed that β = 2e-05, γ = 0.008, and µ= 0.00141, which reflects a very low chance of transmission rate per infectious individuals. Smoothing spline regression model was conducted to predict the number of cumulative infected cases among the three mentioned countries. Figure 6 showed that the cumulative infected cases exponentially increased among the three studied countries; moreover, the performance of the predictive model when tested, the results were excellent.

As the data we relied on was limited, and to predict the proportion of cumulative infected cases to all population and test the performance of the model, we split the data into knots, then we calibrated the model with the 1 st days of data (from the start of positive cases till April 14) to predict the test data (the rest of data points from April 15, 2020, till May 1, 2020). Then, we compared the simulated test data from the model and the original data point to test the model's ability in replicating the rest of the data points. The following equation was established:

Where y in KSA was the square root of infected cases while in Iran and Pakistan, it was the log of infected cases. In Iran [ Figure 7a ], and as our data were during the period from February 20 to April 14, the data were split into knots (0.1, 0.25, and 0.35) at a time in days, and we calibrated the model with the days of data to predict the test data. Then, the model is used to predict the proportion of cumulative infected cases to all populations from April 15 to May 1, according to that, we expected that the cases in Iran would increase to 100485 on May 1.

In KSA [ Figure 7b ], during the period from March 3 to April 14, the data were split into knots (0.5, 0.15, and 0.2) at a time in days and calibrated the model with the 1 st days of data to predict the test data. Then, the model predicted the proportion of cumulative infected cases to all populations from April 15 to May 1. We expected the cases to reach to 16848 by May 1, 2020

In Pakistan [ Figure 7c ], during the period from February 27 to April 14, we split data into Knots (0.15, 0.25, and 0.3) at a time in days, so we calibrated the model with the 1 st days of data and predicted the test data. Then, the model is used to predict the proportion of cumulative infected cases to all population from April 15 to May 1, we expected that the cases will reach 11825 by May 1, 2020.

Regarding testing the performance of the suggested model, in KSA, 99.94% of cases were predicted correctly during the training period and about 99.73% during the testing period. The numbers in Iran and Pakistan were comparable, in Iran, R 2 = 0,9996 and 0.9928 compared to 0.9992 and 0.967 in Pakistan for the training and testing periods consecutively. The root main square error values in the three countries during the testing and training periods were <1, as illustrated in Figure 6 . Figures 8 and 9 consecutively showed the observed cumulative recovered and cumulative deaths as best fitted to the spline regression prediction curve among the three mentioned countries.

Fitting of cumulative recovered cases with the smoothing spline regression prediction model, the dots represent the observable cases while the blue line represents the simulated cases.

Fitting of cumulative death cases with the smoothing spline regression prediction model, the dots represent the observable cases while the blue line represents the simulated cases.

Among the Eastern Mediterranean Region, Qatar followed by Al Bahrain showed the highest prevalence of COVID-19. That was obviously due to their small number of populations, as the population number in Qatar is 2,750,000 and in Al Bahrain is 1,425,000 which is considered the least population number following Djibouti among the region.

Among the three studied countries (Iran, KSA, and Pakistan), Iran significantly showed the highest number of infected cases followed by KSA and lastly Pakistan. Moreover, in a similar way, the highest recovery and deaths were also evident in Iran when compared with KSA and Pakistan. On the other hand, the infection rate in Pakistan was less than KSA, the low infection rate observed in Pakistan was in agreement with Mukhtar and Mukhtar [31] who mentioned that due to the early strict preventive measures and screening implemented by the government, the infection rate in Pakistan was noticed to be less than other countries in the same region. Another explanation might be the lack of screening measures implemented in Pakistan if compared to KSA. However, this situation is not expected to continue as Zhan et al. [32] expected in their studies conducted in Iran and Pakistan that the number of infected cases would grow exponentially by time.

Despite the infection rate in KSA was significantly higher than Pakistan in the first 4 weeks of disease spread, there was no significant difference between them in the death rate. This might be explained by the significantly high recovery rate in KSA compared to Pakistan. The high recovery rate in KSA in comparison to Pakistan could be attributed to the more advanced health-care system in KSA in contrary to Pakistan.

According to the WHO, the total expenditure on health per capita in KSA is 2466 USD compared to 129 USD in Pakistan; furthermore, the total expenditure on health as % of growth domestic product is 4.7 in KSA compared to 2.6 in Pakistan.

Those results were agreed with Raza et al., [28] who mentioned that during the upcoming weeks, 90 million of the population are likely to become infected and the death rate is expected to increase, and if occurred, the health-care system would not be able to deal with this enormous pandemic.

Prediction of the disease peak and expected number of cases among different countries are points of interest for many researchers who built their expectations on the pattern of disease spread in similar countries. China and Italy were on top of the countries who suffered from the COVID-19 pandemic, they both reported exponential growth of infected cases and fatalities with unfortunate still wise expectations. Hence, we tried to implement a predictive model to assess the situation in the Eastern Mediterranean region, notably the situation in KSA. [33] Many models were applied in different studies of different countries in the area. For instance, the augmented SEIR model was conducted in Iran by Zhan et al., [32] Generalized additive model and restricted maximum likelihood by Zareie et al. [34] and Gompertz model by Ahmadi et al. [27] In Pakistan, Raza et al. [28] and Syed and Sibgatullah (2020) [35] applied the SIR model in their studies. The studies in KSA are still lacking and up to our knowledge, this is the first study that aims to predict the coming situation in KSA.

SIRD model is one of the most predominant models used to assess the progression of communicable diseases among different societies. In this model, the whole population is classified into four categories, everyone is considered susceptible, while the other categories involved the infected, recovered, or died cases. Application of this model in Iran, Saudi Arabia, and Pakistan highlighted that the COVID19 transmission rate was so slow among the three countries as <1 person was expected to be infected when comes in contact with the positive case. Added to that and due to the limited data about the susceptible populations in WHO reports, the fraction of infectious, recovered, and died individuals exhibit the plateau-like curves. Fortunately, enough, the basic reproduction numbers in the three mentioned countries during the 1 st weeks of the disease were evidently below that reported in Wuhan, China (3.58), [36] and Italy (2.76-3.25). [33] According to the WHO situational reports, the spread of disease in Iran started earlier on 20 th of February, the basic reproduction number mentioned in the current study that covers the period from February 20 to April 14 was 0.0015, which is less than the number mentioned by many studies conducted in Iran. Sahafizadeh and Sartoli [37] reported decreasing R 0 values from 4.86 during the 1 st week of the outbreak to 2.1 by March 18 and Zhao et al. [38] reported R 0 between 2.24 and 3.58. This discrepancy in the basic reproductive number between the results obtained in the current study and other studies could be explained by the difference in the period during which the studies were conducted. Different sources of data were another reasonable explanation, as Sahafizadeh and Sartoli [37] results were built on Iranian government reports not on WHO situational reports. However, the development of health-care services and the later preventive measures implemented by the government might be another reason. These results are in agreement with Zahiri et al. [39] and Li et al. [40] who expected more decrease in the basic reproduction number by the time.

None of the previous studies tried to use the smoothing spline regression prediction model that was utilized in the current study and proved to predict an exponential growth in cumulative infected cases among Iran, KSA, and Pakistan. However, the expected growth mentioned in the current study is not explained only by cases got the infection directly (R 0 ), but also by others coming from countries where the disease is pandemic, moreover, we suppose the stability of the screening methods implemented by the governments. Those results were in agreement, other studies utilized different models as Syed and Sibgatullah [35] and with Ahmadi et al., [27] who expected exponential growth of cases with time in Pakistan. Among the Eastern Mediterranean Region, the delayed appearance of cases in KSA (March 3) in comparison to Iran and Pakistan which reported the positive cases earlier was attributed to that the early strict quarantine preventive measures implemented by KSA. Al-Tawfik and Memish [41] mentioned the preventive measures implemented by KSA government to overcome the spread of COVID-19 pandemic. On 5 th of February and before the appearance of any confirmed cases, Saudi Arabia suspended the travel to China, a short time after and on 26 th of February, the country suspended the entry for Umrah or tourist visa, according to Ebrahim and Memish, [42] Umrah suspension was a mandatory decision that reduced the infection rate in the country. The first case reported by the Saudi Ministry of Health was coming from Iran. Shortly after, many congregation events were canceled. By March, and as the infection rate increased, more strict preventive measures were implemented as all air flights were suspended, universities and schools were suspended, and that was followed by the partial lockdown. However, this partial lockdown was converted into complete in the Capital City Riyadh, and among the Holy Districts, Mecca and Medina.

In the eastern Mediterranean Region, especially in KSA, Iran, and Pakistan, the cumulative infected cases were expected to grow exponentially, so the quarantine preventive measures should be maintained or even enhanced. It is expected that by May 1, 2020, the number of cumulative infected cases would rise to 16848 in KSA and 11,825 in Pakistan, while In Iran, it is expected that the number mostly will be 10,0485.

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

COVID-19) Situation Report 9-85

The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

A novel coronavirus from patients with pneumonia in China

Identification of a novel coronavirus causing severe pneumonia in human: A descriptive study

) and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status

COVID-19: The new threat

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine

The fight against the 2019-nCoV outbreak: An arduous march has just begun

Hypothesis for potential pathogenesis of SARS-CoV-2 infection--a review of immune changes in patients with viral pneumonia

Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)

COVID-19: What is next for public health?

Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study

Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: Key points for the radiologist

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19)

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

The COVID-19 epidemic

Modeling and forecasting trend of COVID-19 epidemic in Iran until May 13, 2020

Transmission Potential and Severity of COVID-19 in Pakistan

COVID-19 Coronavirus Pandemic

Space-time dependence of corona virus

COVID-19): Let's prevent not panic

Prediction of COVID-19 spreading profiles in South Korea, Italy and Iran by data-driven coding

COVID-19 and Italy: What next?

A model for COVID-19 prediction in Iran based on China parameters

Estimation of the final size of the COVID-19 epidemic in Pakistan

A mathematical model for simulating the phase-based transmissibility of a novel coronavirus

Estimating the reproduction number of COVID-19 in Iran using epidemic modeling

The basic reproduction number of novel coronavirus (2019-nCoV) estimation based on exponential growth in the early outbreak in China from 2019 to 2020: A reply to Dhungana

Prediction of peak and termination of novel coronavirus covid-19 epidemic in Iran

Propagation analysis and prediction of the COVID-19

COVID-19 in the Eastern Mediterranean region and Saudi Arabia: Prevention and therapeutic strategies

COVID-19: Preparing for superspreader potential among Umrah pilgrims to Saudi Arabia

We would like to extend our gratitude to the WHO and Worldometer for sharing their data on their official websites and making them accessible. Furthermore, we are immensely grateful to the reviewers for their so-called insights.ORCID ID link of the submitting author: ORCID ID: 0000-0002-0866-0981Asmaa Sharif-ORCID ID:0000-0002-6104-562X Sara Mattout -ORCID ID:0000-0002-3746-2757

We recommend conducting the study on longer time intervals and comparing the predictive power of different models with the SIRD and smoothing spline regression model.The model is based on the routine circumstantial screening measurements implemented by the different countries. Introducing of new screening methods or applying screening on a larger scale would be associated with a total number of cumulative cases that exceed those predicted in the current study.

The data used in this study are available and will be provided by the corresponding author on a reasonable request.

All authors declare that they have no conflicts of interest

The research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

All authors contributed equally in the article.